Suzhou Shengnuo Biological Medicine Technology Co.,Ltd.
圣诺医药Sirnaomics
Suzhou Shengnuo Biological Medicine Technology Co.,Ltd.
Biotech/Healthcare
Sirnaomics is a developer of RNA interference (RNAi) drugs, primarily engaged in the R&D and commercialization of RNAi drug candidates that have entered clinical trials. Its lead candidate, STP705, based on its dual-targeting mechanism and early safety results, is currently being studied in a Phase…
Latest round: Strategic (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.